Latest News

Isotopia Announces the Launch of Isoprotrace® in the Czech Republic, an Innovative Diagnostic Solution for Prostate Cancer Imaging

Czech Republic, May 20, 2026 Czech Republic, May 20, 2026 Isotopia Molecular Imaging is proud to announce the official launch ...

Isotopia Strengthens Manufacturing Capabilities with Modiin Relocation

Petah Tikva, September 25, 2025 Petah Tikva, September 25, 2025 Isotopia Announces: Aseptic Manufacturing Plant Relocates from...

Isotopia Launches Isoprotrace® in Malta — Empowering Precision Imaging in Prostate Cancer Diagnosis

Malta, November 4, 2025 Malta, November 4, 2025 Isotopia Molecular Imaging proudly announces the launch of Isoprotrace®, an ad...

Isotopia and Cardirad Announce Launch of Isoprotrace® in Sweden and Denmark, Expanding Access to Advanced Prostate Cancer Imaging

Petah Tikva, May 30, 2025 Petah Tikva, May 30, 2025 Isotopia Molecular Imaging, in partnership with Cardirad , proudly announc...

Isotopia and ASP Isotopes Announce Supply Agreement for Gadolinium-160 to Accelerate Terbium-161 Production for Advanced Cancer Therapies

Petah Tikva, June 1st, 2025 Petah Tikva, June 1st, 2025 Isotopia Molecular Imaging Ltd. and ASP Isotopes Inc. (NASDAQ: ASPI) h...

Isotopia Announces Launch of Isoprotrace® in Greece, Expanding Access to Advanced Prostate Cancer Imaging

Petah Tikva, July 21, 2025 Petah Tikva, July 21, 2025 Isotopia Molecular Imaging is proud to announce the official launch of I...

Isotopia Announces Official Commercial Launch of Isoprotrace® in Germany in Partnership with DSD Pharma

Petah Tikva, Israel ,Feb 11th, 2025 Petah Tikva, Israel ,Feb 11th, 2025 – Isotopia, a leading developer of innovative radio-ph...

Isoprotrace® Receives Marketing Authorization in Denmark

Petah Tikva, Israel, February 19th, 2025 Petah Tikva, Israel, February 19th, 2025 Isotopia is excited to announce that Isoprot...

Isoprotrace® Receives Marketing Authorization in the United Kingdom for Prostate Cancer Imaging

We are thrilled to announce that Isoprotrace®, our Gallium-68 Gozetotide preparation kit for prostate cancer imaging, has received...

Isoprotrace now available in the United Kingdom

Petah Tikva, Israel ,April 10th, 2025 Petah Tikva, Israel ,April 10th, 2025 Isotopia Molecular Imaging is proud to announce th...

Kinectrics and Isotopia Enter Agreement for Supply of Gadolinium-160 (Gd-160) to Support Production of Terbium-161 (Tb-161)

Toronto, Canada,Jan 29th, 2025 Toronto, Canada,Jan 29th, 2025 Kinectrics and Isotopia have announced a groundbreak...

Isotopia USA partners with E Solutions and Comfort Systems

Isotopia USA and E Solutions have finalized agreements to collaboratively design and construct their cutting-edge GMP manufacturin...

Isoprotrace® received marketing authorization in the Netherlands

We are thrilled to announce that Isoprotrace®, our PSMA -11 kit, has received marketing authorization in the Netherlands (RVG 1305...

Immunity Pharma Ltd (IPL) & Isotopia Molecular Imaging Ltd Signed a Strategic Agreement for Clinical Contract Manufacturing Services

August 2024, Petach Tikva, Israel August 2024, Petach Tikva, Israel Isotopia Molecular Imaging Ltd. (Isotopia) and I...

Isotopia is exhibiting at the EANM 2024 conference in Hamburg from October 19-23 at Booth H45. Let’s connect!

Isotopia at EANM 2024: Join Us in Hamburg! Isotopia is exhibiting at the EANM 2024 conference in Hamburg from October 19-23 at Bo...

Isoprotrace® Officially Approved in the Netherlands

We are pleased to announce that Isoprotrace®, our kit for preparation of Gallium-68 Gozetotide, has received official approval for...

Isotopia Molecular Imaging Ltd. to Showcase Innovation in Targeted Radiopharmaceuticals at the TRP Summit

TRP Summit Israel – November 2024 TRP Summit Israel – November 2024 Isotopia is excited to announce its participation in the T...

Breakthrough in Lupus Treatment: Isotopia Partners with LIVEKIDNEY.BIO

Petach Tikva, Israel, December 12th, 2024 Petach Tikva, Israel, December 12th, 2024 Isotopia is proud to announce a ...

Isotopia Molecular Imaging and Sinotau Pharmaceuticals Sign a Clinical Supply Agreement for 177Lu n.c.a

Petach Tikva, Israel, and Beijing China 19 Oct 2021 Petach Tikva, Israel, and Beijing China 19 Oct 2021 Isotopia M...

Enhancing capacity and synthesis of [68Ga]68-Ga-PSMA-HBED-CC with the lyophilized ready-to-use kit for nuclear pharmacy

In the 60's- Gallium-68 (Ga-68)-labeled tracers for imaging expression were developed. In the 2000's- Gallium-68 (Ga-68)-labeled ...

National Comprehensive Cancer Network® (NCCN) Guidelines® Version 03/2022

(NCCN) Guidelines® Version 3.2022 for prostate cancer now contains a recommendation for the use of Ga-68 PSMA-11 PET / CT for bone...

We are looking for a VP of sales in Europe

We are looking for a VP of sales in Europe, preferably in Germany as a top-level executive in sales and business-oriented. The ide...

SNMMI 2022 annual meeting, 11-14, in Vancouver, Canada

We look forward to seeing you at the SNMMI 2022 annual meeting, held June 11-14- in Vancouver, Canada.  Learn more about our to...

6th Theranostics World Congress- June 24-26, 2022- Wiesbaden, Germany

Take a 360° view of the field of Theranostics and Radiomolecular Precision Medicine (RPM). We are proud to take part in the 6th...

Isotopia and CPDC Successfully Deliver First Doses of n.c.a. Lu-177 to North American Customers

June 9th, 2022 – Israel and Canada June 9th, 2022 – Israel and Canada Isotopia and CPDC shorten arrival time to pati...

Advancing clinical journey with our partners

Partnerin with Radiopharm (ASX:RAD) to extend the clinical journey to find the best therapies against cancer. ...

Clovis Oncology and Isotopia Announce Lutetium-177 Clinical Supply Agreement

/*! elementor - v3.7.6 - 15-09-2022 */.elementor-widget-tabs.elementor-tabs-view-vertical .elementor-tabs-wrapper{width:25%;-ms-fl...

Pilochem AG, Seibersdorf Labor GmbH and Isotopia announce supply, development, and manufacturing agreements

December 13th , 2022 December 13th , 2022 Pilochem, Seibersdorf Laboratories and Isotopia Molecular Imaging have tod...

Pilochem AG, Seibersdorf Labor GmbH and Isotopia announce supply, development, and manufacturing agreements

December 13th , 2022 December 13th , 2022 Pilochem, Seibersdorf Laboratories and Isotopia Molecular Imaging have today announc...

Successful implementation of a GMP-compliant eQMS solution

The implementation of a digitization process for a GMP company like Isotopia posed several challenges. The compliance requirements...

Isotopia is expanding its global footprint after filling a DMF in the US FDA and MF in Canada

Isotopia has received the Adoption of COMMISSION IMPLEMENTING DECISION granting marketing authorization (MA) under Regulation (EC)...

Todd Hockemeyer, CEO- Isotopia USA

We are thrilled to announce our plans to establish a cutting-edge isotopes manufacturing site in the USA.  Our goal is to provide...

Isotopia and Eckert & Ziegler to start Partnership for Prostate Cancer Imaging

Isotopia and Eckert & Ziegler to start Partnership for Prostate Cancer Imaging Petach Tikva, Israel, 10th February 2020 – Is...

Isotopia's announcement: GMP certificate was given for Lu177 chloride

We are happy to share that we have just received our GMP certificate for Lu177 production. this is the first step towards marketi...

COVID-19 measures – Isotopia Molecular Imaging

COVID-19 measures – Isotopia, Israel. COVID-19 is one of the most challenging pandemics that we have experienced in the last dec...

Isotopia files Drug Master File (DMF) with the U.S. Food and FDA for Lu177 n.c.a

August 19, 2020, Petach Tikva Israel August 19, 2020, Petach Tikva Israel Isotopia is pleased to announce that it ha...

Isotopia and CPDC Announce Production Agreement for n.c.a. Lu-177

Petach Tikva, Israel, 8 Sep 2020 Petach Tikva, Israel, 8 Sep 2020 Isotopia Molecular Imaging and CPDC are pleased to announce tha...

Isotopia begins clinical supply collaboration with Y-mAbs Therapeutics,Inc

November 8 2020, Petach Tikva, Israel Isotopia is pleased to announce that it has begun a collaboration with Y-mAbs Therapeutics...

ARTMS and Isotopia Announce successful Multi-Curie Labeling of PSMA-11

Press release: Press release: Burnaby, Canada and Petach Tikva, Israel, January 19, 2021 ARTMS and Isotopia are pleased to...

Breaking news !

Lu177 is better than cabazitaxel in patients with metastatic castration-resistant prostate cancer. An unblinded, randomized phase...

Isotopia and M.T.T.I signed for the supply of Lu-177 n.c.a

Isotopia Molecular Imaging and Molecular Targeting Technologies (M.T.T.I) havesigned a clinical supply agreement for Lu177 n.c.a.I...

Jubilant Radiopharma and Isotopia Molecular Imaging Enter into a Strategic Partnership to Further Advance the Field of Radiotherapeutics

Our latest news Our latest news Yardley, PA and Petach Tikva, Israel – March 16, 2021. Isotopia Molecular Imaging L...

Israeli researchers developing radioactive marker to detect small, aggressive cancerous tumors

Marker will determine type of tumor in a single image, eliminating the need for a biopsy Today, more than 200,000 cancer patients...

Elgan Pharma and Isotopia Molecular Imaging Signed on a Strategic agreement for Phase III and commercial Contract Manufacturing Services

Latest news from Isotopia Ltd Latest news from Isotopia Ltd Petach Tikva, Israel – May 6st 2021Isotopia and Elgan Ph...

Elementor #3433

Getting to know Isotopia’s supply chain

Join us for this webinar where our own head of therapy Eyal Gimshi will talk about the journey of Lu-177 from starting material to...

POINT Biopharma and Isotopia Announce Lutetium-177 Clinical Supply Agreement

Press release: Press release: July 21, 2021 – INDIANAPOLIS, INDIANA and PETACH TIKVA, Israel POINT Biopharma Globa...

HERMES MEDICAL SOLUTIONS & ISOTOPIA ANNOUNCE A NEW COLLABORATION FOCUSED ON DOSIMETRY

Press Release Press Release Greenville, NC, September 1st, 2021 Hermes Medical Solutions (HMS), global market leader in mol...

Isotopia and FutureChem sign a clinical supply agreement for 177Lu n.c.a

Press Release Press Release Petach Tikva, Israel, 8th Oct 2021 Isotopia is pleased to announce that it has begun ...

Isotopia and Seibersdorf Labor GmbH Announce Production Agreement for 177Lu n.c.a

Press Release Press Release Petach Tikva Israel and Austria, 8th Oct 2021 Isotopia and Seibersdorf Labor are pleas...

Isotopia and the Peter MacCallum Cancer Center announce Terbium-161 clinical study collaboration

October 31st, 2021 – Petach Tikva, Israel and Melbourne, Australia October 31st, 2021 – Petach Tikva, Israel and Melbourn...

Isotopia starts Lu-177 c.a

Since 2018, Isotopia has worked on development of Lu-177 production. Achieving a long term agreement for the supply of raw materi...

EANM 2018 Germany

Isotopia will be in the EANM in duseldorf for the first time. For the 31st time the European Association of Nuclear Medicine host...

F-DOPA reimbursed for Israeli patients

January, lsotopia promoted inclusion of F-18-DOPA in the Israeli medical health insurance for reimbursement for diagnosis of n...

15th Annual Update Conference on Clinical Neurology & Neurophysiology

February (1819.2.19): Isotopia took part in The15th Annual Update Conference on Clinical Neurology & Neurophysiology, Tel Av...

Isotopia participated in the PDA convention

Isotopia participated in the PDA convention took place in David Intercontinental on March 4TH the subject was - Tech Transfer a...

Isotopia completes the acquisition of the pharmaceutical aseptic plant located in soreq

Isotopia is about to complete the acquisition of the pharmaceutical aseptic plant located in soreq. The agreement  was signed in m...

Israeli Nuclear Medicine Conference INM

This month (7-9.3.19) Isotopia took part in the Nuclear Medicine Conference organized by Prof. Bar Saver.  The annual congress ...

The first Radio-pharmacy GPP certified

Isotopia is pleased to announce that the company's nuclear pharmacy plant, located in Petach Tikvah, has recently received GPP (...

Lu-177 n.c.a status update

Isotopia is proud to share that we have finalized Conducting "cold" and "hot" feasibility tests for Lu-177 n.c.a production  Afte...

FDA inspection

Isotopia Soreq happy and proud to update on completing a US FDA inspection conducted in the site. It was a busy summer and now it...

EANM 2019 Barcelona

Isotopia participated in the EANM congress, the world largest congress the EANM annual meeting is the world-reference congress i...

Tech transfer for isoPROtrace-11 completed

Isotopia is happy to announce that the Tech- Transfer of isoPROtrace-11 production to our newly acquired sterile plant has come to...

Hanukkah 2019 - Family day at Isotopia

  Family day at Isotopia on the eighth candle of Hanukkah, balloons, guided tours and experiments   ...

CNIC establishes global partnership with Isotopia to put patients first

Press relese: Press relese: November 2019, Isotopia CINC Press, Toronto Isotopia - a private Canadian funded international dev...